Page last updated: 2024-09-05

phosphatidylcholines and Colorectal Cancer

phosphatidylcholines has been researched along with Colorectal Cancer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Chen, H; Huang, Z; Liang, Y; She, Z; Wang, X; Wei, Z; Yang, S; Zhang, Q; Zhou, H1
Menon, I; Shaji, J1
Bathe, OF; Buie, WD; Farshidfar, F; Hilsden, R; Kopciuk, KA; MacLean, A; Mazurak, VC; McGregor, SE; Vogel, HJ1
Aires, V; Cotte, AK; de Barros, JP; Delmas, D; Derangère, V; Fredon, M; Ghiringhelli, F; Hillon, P; Humblin, E; Limagne, E; Scagliarini, A; Thibaudin, M1
Arias, JL; Cabeza, L; Clares, B; Delgado, ÁV; Halbaut, L; Lorente, C; Melguizo, C; Ortiz, R; Perazzoli, G; Prados, J1
Phyu, SM; Smith, TAD; Tseng, CC1
Hayasaka, T; Ide, Y; Kahyo, T; Kurabe, N; Kurachi, K; Masaki, N; Midorikawa, Y; Nakamura, T; Ogawa, M; Setou, M; Shinmura, K; Sugimura, H; Sugiyama, Y; Waki, M1
Banerjee, S; Erdoğ, A; Keskin, D; Putra Limasale, YD; Tezcaner, A1
Franzen, U; Gammelgaard, B; Nguyen, TT; Ostergaard, J; Vermehren, C1

Other Studies

9 other study(ies) available for phosphatidylcholines and Colorectal Cancer

ArticleYear
UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
    Journal of pharmaceutical and biomedical analysis, 2023, Sep-20, Volume: 234

    Topics: Adenoma; Biomarkers; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Humans; Lipidomics; Phosphatidylcholines; Sphingomyelins

2023
PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Pharmaceutical nanotechnology, 2017, Volume: 5, Issue:2

    Topics: Antineoplastic Agents; Cell Survival; Colorectal Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; HT29 Cells; Humans; Liposomes; Meloxicam; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols

2017
A quantitative multimodal metabolomic assay for colorectal cancer.
    BMC cancer, 2018, 01-04, Volume: 18, Issue:1

    Topics: Adenoma; Aged; Amino Acids; Biomarkers, Tumor; Carnitine; Colorectal Neoplasms; Early Detection of Cancer; Female; Humans; Male; Mass Spectrometry; Metabolome; Metabolomics; Middle Aged; Phosphatidylcholines; Sphingomyelins

2018
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.
    Nature communications, 2018, 01-22, Volume: 9, Issue:1

    Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Caspases; CD8-Positive T-Lymphocytes; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Homeostasis; Humans; Lipids; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Phenotype; Phosphatidylcholines; Triglycerides

2018
Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy.
    Colloids and surfaces. B, Biointerfaces, 2018, Nov-01, Volume: 171

    Topics: Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Drug Carriers; Drug Screening Assays, Antitumor; Ferric Compounds; Humans; Liposomes; Magnetite Nanoparticles; Mice; Nanotechnology; Particle Size; Phosphatidylcholines; RAW 264.7 Cells; Surface Properties

2018
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
    Magma (New York, N.Y.), 2019, Volume: 32, Issue:2

    Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Choline; Colorectal Neoplasms; Cytidine Diphosphate Choline; Enzyme Inhibitors; Female; Glucose; Glycogen Synthase Kinase 3; Humans; Indoles; Lipid Metabolism; Magnetic Resonance Spectroscopy; Maleimides; Phosphatidylcholines

2019
Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4.
    Cancer science, 2013, Volume: 104, Issue:10

    Topics: 1-Acylglycerol-3-Phosphate O-Acyltransferase; 1-Acylglycerophosphocholine O-Acyltransferase; Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Proteins; Phosphatidylcholines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2013
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:10

    Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Colorectal Neoplasms; Drug Delivery Systems; HCT116 Cells; HT29 Cells; Humans; Liposomes; Phosphatidylcholines; Polyethylene Glycols; Pyrazoles; Sulfonamides

2013
Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.
    Journal of pharmaceutical and biomedical analysis, 2011, Apr-28, Volume: 55, Issue:1

    Topics: Algorithms; Antineoplastic Agents; Colorectal Neoplasms; Drug Compounding; Drug Delivery Systems; Drug Stability; Electrophoresis, Capillary; Liposomes; Organoplatinum Compounds; Oxaliplatin; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Solubility; Spectrophotometry, Atomic

2011